1Coulter DM.The New Zealand intensive medicines monitoring programe in pro-active safety surveillance[J].Pharmacoepidemiol Drug Safe, 2000,9:273-280.
2Mackay FJ.Post-marketing studies. The work of the Drug Safety Research Unit [J].Drug Safety, 1998,19:343-353.
3Garcia RLA, Perez GS. Use of the UK General Practice Research Database for Pharmacoepidemiology [J].Br J Clin Pharmucol ,1998,45:419-425.
4World Health Organization. WHO Collaborating Centre for Drug Monitoring. The importantce of pharmacovigilance [J].Safety monitoring of medicinal products, 2002.
5Evens SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports [J].Pharmocoepidemiol Drug Safe, 2001, 10: 483-486.
6Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio [J].Pharmacoepidemiol Drug Safe, 2004, 13:519-523.
7Bate A, Lindquist M, Edwards IR. A Bayesian neural network method for adverse drug reaction signal generation [J].Eur J Clin Pharmacol.1998,54:315-321.
8Van Puijenbroek E, Egberts ACG, Heerdink ER, et al. Detecting drug -drug interactions using a database for spontaneous adverse drug reactions: An example with diuretics and non-steroidal anti-inflammatory drugs [J].Eur J Clin Pharmacol.2000,56:733-738.
9Shapiro S.Clinical judgment, common sense and adverse reaction reporting[J].Pharmacoepidemiol Drug Safe, 2004,13:511-513.
